Technology News and Research

RSS

Inovio's SynCon DNA vaccine effective at inducing CD8+ T cell responses specific to CMV

Inovio Pharmaceuticals, Inc. announced today that testing of multiple synthetic vaccine constructs for cytomegalovirus (CMV) induced robust T cells in mice, demonstrating the potential for a SynCon DNA vaccine to treat this virus that causes infant death and congenital abnormalities, is associated with cerebral palsy and brain tumors, and is the most common viral infection in organ transplant recipients. CMV is also associated with numerous inflammatory diseases and cancers, and is implicated in hypertension, a major risk factor for cardiovascular diseases.

26 Nov 2012

Toshiba showcases innovations to improve workflow and image quality at RSNA 2012

To expand imaging capabilities and improve department productivity, Toshiba America Medical Systems, Inc. is showcasing new and future innovations for the Aplio 500 and Aplio 300 ultrasound systems at this year's Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 25 - 30, 2012 (Booth #3438, South Hall).

26 Nov 2012

Mental activities like reading and writing can preserve structural integrity in the brains of older people

Mental activities like reading and writing can preserve structural integrity in the brains of older people, according to a new study presented today at the annual meeting of the Radiological Society of North America (RSNA).

26 Nov 2012

Toshiba to showcase scalable Vantage Titan 1.5T MR series at RSNA 2012 meeting

Providing hospitals with MR technology that fulfills their financial needs and grows with their clinical needs, Toshiba America Medical Systems, Inc. will showcase the scalable Vantage Titan™ 1.5T MR series, which includes 8-, 16- and 32-channel MR systems, at this year's Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 25 - 30, 2012.

26 Nov 2012

Toshiba launches PROTECT program for both radiologists and patients

To ensure the lowest possible CT radiation dose without compromising image quality, Toshiba America Medical Systems, Inc. launches PROTECT. PROTECT is a three-year, comprehensive CT radiation dose management program to help customers achieve ALARA (as low as reasonably achievable) imaging with Toshiba's Aquilion CT product line.

26 Nov 2012

Apitope announces completion of recruitment in ATX-MS-1467 Phase I trial for MS

Apitope, the European drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announced completion of recruitment into its second Phase I clinical trial of ATX-MS-1467 in patients with multiple sclerosis (MS).

26 Nov 2012

Philips launches Imaging 2.0 at RSNA 2012 meeting

At the 98th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Royal Philips Electronics is unveiling the company's next chapter of its unique approach to radiology, Imaging 2.0, by demonstrating new products that enable and improve collaboration among caregivers and integration among systems to transform care together.

From Philips Healthcare 26 Nov 2012

GE Healthcare introduces new LOGIQ E9 with XDclear

Today at RSNA 2012, GE Healthcare is introducing the new LOGIQ E9 with XDclear, a new general imaging ultrasound system.

26 Nov 2012

Study shows how MCUR1 protein helps regulate movement of calcium into mitochondria

A team of scientists from Temple University School of Medicine and the University of Pennsylvania has moved another step closer to solving a decades-long mystery of how the all-important flow of calcium into the cell's power source, the mitochondria, is controlled.

26 Nov 2012

FDR AcSelerate integrates Dual Energy Subtraction and Tomosynthesis

FDR AcSelerate, the fully automated positioning DR system from FUJIFILM Medical Systems U.S.A., Inc., will integrate two advanced applications to further extend diagnostic capabilities: Dual Energy Subtraction (DES) and Tomosynthesis (TS).

26 Nov 2012

New dental practice management software from Henry Schein

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, today announced the launch of "Viive," a new dental practice management software for the Apple Mac computer.

26 Nov 2012

iCAD introduces VersaVue Enterprise 3.2.1 MR software

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the identification and treatment of cancer, announced today it will launch VersaVue Enterprise 3.2.1, the latest release of the company's MR software solution that provides improvements in workflow efficiency and flexibility, at the annual conference of the Radiological Society of North America (RSNA) taking place in Chicago, November 25-30.

26 Nov 2012

mRNA vaccines offer protection against influenza A virus infections in various animal models

CureVac GmbH, a clinical stage biopharmaceutical company developing a new class of therapies and vaccines based on mRNA, and the German Federal Research Institute for Animal Health, Friedrich-Loeffler-Institute (FLI), Germany, today announced that mRNA vaccines (RNActive) based on the company's RNA technology platform have the potential to provide effective protection against infectious diseases.

26 Nov 2012

Ivoclar Vivadent announces acquisition of Wieland Dental

Ivoclar Vivadent, headquartered in Schaan, Liechtenstein, announced the acquisition of Wieland Dental today. The acquisition is planned to be completed in the fourth quarter of 2012. The transaction is still subject to approval by the German Federal Cartel Office.

26 Nov 2012

Official stats underestimate brain injury

A population-based study suggests that the true incidence of traumatic brain injury is about sixfold higher than official figures state.

23 Nov 2012

Lymphopenia driven diseases and the orphan drug industry: an interview with Damian Marron, CEO of Cytheris

Lymphopenia is when you lack the T cells of your immune system. T cells are very important for controlling infection. Probably the most known cause of lymphopenia is HIV.

23 Nov 2012

Researchers trace specific paths of chandelier cells during development into the cerebral cortex

The cerebral cortex of the human brain has been called "the crowning achievement of evolution." Ironically, it is so complex that even our greatest minds and most sophisticated science are only now beginning to understand how it organizes itself in early development, and how its many cell types function together as circuits.

23 Nov 2012

Major advance in understanding how flu viruses replicate within infected cells

Scientists at The Scripps Research Institute (TSRI) have made a major advance in understanding how flu viruses replicate within infected cells. The researchers used cutting-edge molecular biology and electron-microscopy techniques to "see" one of influenza's essential protein complexes in unprecedented detail. The images generated in the study show flu virus proteins in the act of self-replication, highlighting the virus's vulnerabilities that are sure to be of interest to drug developers.

23 Nov 2012

People worried about catching infections in public transport during flu season

As flu season gets underway, public transport such as buses, trains and subway trains head the list of places where people worry about catching viruses and infections, according to new research by Microban.

23 Nov 2012

Collaborative research on fruits that may help improve vascular health

Scientists at the University of Warwick and consumer goods manufacturer Unilever are joining forces to identify whether the nutrients in everyday fruit and vegetables could help to improve people's cardiovascular health and protect them from Type-2 diabetes.

23 Nov 2012